Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPY5R | Q15761 | 19/20 | 0.59 |
| ▸ | GAA | P10253 | 1/20 | 0.50 |
| ▸ | TSHR | P16473 | 1/20 | 0.50 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.50 |
| ▸ | NPY1R | P25929 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL10546714 | 0.91 | NPY5R (0.56) | NPY5RGAATSHRNPSR1NPY1R | |
| Hydrochloric Acid SCHEMBL10546442 | 0.88 | NPY5R (0.60) | NPY5RGAATSHRNPSR1NPY1R | |
| SCHEMBL10543920 | 0.87 | TDP1 (0.57) | NPY5RGAATSHRNPSR1 | |
| SCHEMBL10542787 | 0.85 | NPY5R (0.57) | NPY5RGAATSHRNPSR1NPY1R | |
| SCHEMBL10546428 | 0.85 | NPY5R (0.59) | NPY5RGAATSHRNPSR1 | |
| SCHEMBL10547065 | 0.84 | NPY5R (0.54) | NPY5RNPY1R | |
| SCHEMBL10546335 | 0.84 | NPY5R (0.59) | NPY5RGAATSHRNPSR1 | |
| SCHEMBL10547671 | 0.83 | NPY5R (0.61) | NPY5RGAATSHRNPSR1 | |
| Hydrochloric Acid SCHEMBL10543860 | 0.83 | NPY5R (0.58) | NPY5RGAATSHRNPSR1 | |
| SCHEMBL10543762 | 0.83 | NPY5R (0.59) | NPY5RNPY1R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-4797399-A | ANTIINFLAMMATORY AGENTS, ANTICOAGULANTS ANTIALLERGENS | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1989-01-10 | — | — | US | disclosed |
| EP-0232740-A1 | N-containing fused heterocyclic compounds, processes for the preparation thereof and pharmaceutical compositions comprising the same | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1987-08-19 | — | — | EP | disclosed |